The Jenner Institute is a research partnership between the University of Oxford and The Pirbright Institute.
The Institute focuses on the parallel development of human and vetinary vaccines against major global diseases - from early-stage research through to clinical trials.
A vaccine against Malaria, developed at the Jenner Institute, has shown promising results in its first field trial. The trial in Kenya found that the vaccine was 67% effective against Plasmodium falciparum infections - see BBC report.
Applications are now open for this year's 'Vaccinology in Africa' Master's level course, held in Bamako, Mali, from 5 - 9 October. Over 20 top international and regional vaccinology experts will be teaching 40 participants from West and Central Africa in human and veterinary vaccinology.
Application deadline: 1 June 2015.
Prof Joanna Shisler (University of Illinois): To be announced, 01 Jun 12:00
Searching for the human genetic factors standing in the way of universally effective vaccines. Philos Trans R Soc Lond B Biol Sci , 370 (1671)
The Regulatory Role of Invariant NKT Cells in Tumor Immunity. Cancer Immunol Res , 3 (5)
Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.
If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.